home / stock / tpst / tpst news

TPST News and Press, Tempest Therapeutics Inc. From 02/10/25

Stock Information
Company Name: Tempest Therapeutics Inc.
Stock Symbol: TPST
Market: NASDAQ
Website: tempesttx.com
Menu
TPST TPST Quote TPST Short TPST News TPST Articles TPST Message Board
Get TPST Alerts

News, Short Squeeze, Breakout and More Instantly...
TPST - Tempest gets fast track designation from FDA for amezalpat

2025-02-10 08:26:35 ET More on Tempest Therapeutics Seeking Alpha’s Quant Rating on Tempest Therapeutics Historical earnings data for Tempest Therapeutics Financial information for Tempest Therapeutics Read the full article on Seeking Alpha For...
TPST - Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-...

TPST - Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)

BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated therapeutics to fight cancer, today announced that the U.S. Food and Drug Administration (FDA) has gra...

Previous 10 Next 10